Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
BriaCell Therapeutics Corporation | BCTX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.19 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 2.01 - 7.59 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 2.19 | USD |
BriaCell Therapeutics Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
169.41M | 15.98M | - | 0 | -20.3M | -1.27 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
BriaCell Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BCTX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.13 | 2.37 | 2.01 | 2.17 | 25,226 | 0.06 | 2.82% |
1 Month | 2.64 | 3.03 | 2.01 | 2.59 | 52,832 | -0.45 | -17.05% |
3 Months | 4.11 | 4.35 | 2.01 | 3.03 | 85,498 | -1.92 | -46.72% |
6 Months | 4.90 | 5.97 | 2.01 | 3.94 | 99,517 | -2.71 | -55.31% |
1 Year | 7.12 | 7.59 | 2.01 | 5.18 | 98,734 | -4.93 | -69.24% |
3 Years | 3.39 | 12.47 | 2.01 | 6.84 | 867,009 | -1.20 | -35.40% |
5 Years | 4.24 | 12.47 | 2.01 | 6.62 | 890,612 | -2.05 | -48.35% |
BriaCell Therapeutics Description
BriaCell Therapeutics Corp is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer. BriaCell, in collaboration with Incyte Corp., is conducting a Phase I/IIa clinical trial of Bria-IMT, its lead candidate, in a Combination Study with Incyte drugs, INCMGA00012, and epacadostat, in advanced breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for advanced breast cancer. Bria-OTS immunotherapy treatments are personalized to match the patient without the need for personalized manufacturing and is designed to produce a potent and selective immune response against the cancer of each patient eliminating the time, expense and complex manufacturing logistics associated with immunotherapies. |